Biotech
-
Business & Markets · Startups COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
Insider Brief Coeptis, Inc. has closed an additional $5.7 million in Series A Preferred funding, bringing the total round to $10 million, reinforcing investor confidence in its AI-driven biotechnology and therapeutic solutions. The funding,… -
Business & Markets · Startups Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics
-
Business & Markets · Startups Manas AI Closes $24.6M Funding Round to Accelerate Drug Discovery with AI
-
Policy & Government · Regulation Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda
-
Business & Markets · Startups Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions
-
Technology & Infrastructure · Applications & agents QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
-
Technology & Infrastructure · Applications & agents Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.